Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Therapeutic approach to fibromyalgia: a consensus statement on pharmacological and non-pharmacological treatment from the neuropathic pain special interest group of the Italian neurological society.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2025

Same author

Search for Leptonic Decays of Dark Photons at NA62.

Physical review letters·2024

Same author

Habitat suitability modelling to predict the distribution of deep coral ecosystems: The case of Linosa Island (southern Mediterranean Sea, Italy).

Marine environmental research·2024

Same author

Transient ischemic attack and minor stroke as "surgeons affairs": a narrative review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2023

Same author

Clinical criteria and diagnostic assessment of fibromyalgia: position statement of the Italian Society of Neurology-Neuropathic Pain Study Group.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2023

Same author

Search for Lepton Number and Flavor Violation in K^{+} and π^{0} Decays.

Physical review letters·2021

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Fibromyalgia comorbidity in primary headaches.

M de Tommaso¹, M Sardaro, C Serpino

¹Neurological and Psychiatric Sciences Department, Neurophysiopathology of Pain Unit, University of Bari, Bari, Italy. m.detommaso@neurol.uniba.it

Cephalalgia : an International Journal of Headache

|January 28, 2009

Summary

Fibromyalgia syndrome (FMS) affects over a third of primary headache patients, particularly those with frequent tension-type headaches. Increased headache frequency, anxiety, and poor sleep are linked to FMS in these individuals.

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Related Experiment Videos

Last Updated: Jun 26, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Area of Science:

Neurology
Pain Medicine
Rheumatology

Background:

Fibromyalgia syndrome (FMS) is a chronic pain disorder with widespread pain and tenderness.
Primary headaches are common neurological conditions managed in specialized centers.
The co-occurrence of FMS and primary headaches requires further investigation.

Purpose of the Study:

To determine the prevalence of FMS in patients with primary headaches.
To identify clinical features associated with FMS in this patient group.
To explore the relationship between headache characteristics and FMS comorbidity.

Main Methods:

A cohort of 217 primary headache patients was assessed.
Standardized questionnaires evaluated FMS, headache features, anxiety, depression, disability, allodynia, and sleep quality.
Specific instruments measured fatigue and tender points in FMS patients.

Main Results:

Fibromyalgia syndrome (FMS) was diagnosed in 36.4% of primary headache patients.
FMS prevalence was higher in tension-type headache and patients with increased headache frequency.
Headache frequency, pericranial tenderness, anxiety, and sleep inadequacy were significantly associated with FMS.

Conclusions:

Fibromyalgia syndrome is highly prevalent in primary headache patients, especially those with frequent headaches.
Anxiety and sleep disturbances may contribute to central sensitization, linking FMS and headaches.
Targeting anxiety and sleep issues could be beneficial for patients with comorbid FMS and headaches.